Evolution Wealth Advisors, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Evolution Wealth Advisors, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$3,000
-66.7%
60
-60.3%
0.00%
-50.0%
Q2 2021$9,000
-35.7%
151
-17.0%
0.00%
-33.3%
Q1 2021$14,000
-30.0%
182
-20.2%
0.00%
-40.0%
Q4 2020$20,000
+5.3%
228
-28.3%
0.01%0.0%
Q3 2020$19,000
+26.7%
318
+55.9%
0.01%
+25.0%
Q4 2019$15,000
+650.0%
204
+1600.0%
0.00%
+300.0%
Q3 2019$2,000
-90.5%
12
-89.6%
0.00%
-88.9%
Q2 2019$21,0001150.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders